Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2810-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15043 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-907 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
filingDate |
2019-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2021-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-110093373-B |
titleOfInvention |
Construction method of AFFT2 cells |
abstract |
The invention belongs to the technical field of biology, and particularly relates to a construction method of AFFT2 cells. The method modifies cells by using a TCR-T technology, the modified T cells are sealed in vitro by using inhibitory signal molecule antibody medicines, so that the anti-tumor capacity of the T cells is effectively improved, and the proportion of specific T cells for recognizing tumor antigens of the cells modified by the AFFT2 scheme is more than 70%. |
priorityDate |
2018-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |